EXECUTIVE PROJECT, PROGRAM & PORTOFLIO MANAGEMENT SUMMIT
Master Strategic Decision-Making in Biopharma R&D
Success in pharmaceutical R&D depends on smart portfolio prioritization, risk mitigation, and data-driven decision-making. The Executive Project, Program & Portfolio Management Summit (EP3M Summit) by Cambridge Healthtech Institute is the premier event for biopharma leaders seeking innovative strategies, cutting-edge tools, and high-impact networking to optimize project planning and portfolio management. Through expert-led panels, case studies, and breakout roundtables, you’ll gain actionable strategies to optimize project planning, strengthen portfolio insights, and drive smarter decisions.
Why Attend?
✅ Industry Expertise – Learn from top executives and thought leaders in pharma and biotech, gaining insights into best practices that enhance decision-making and strategic execution.
✅ Actionable Strategies – Stay ahead with the latest approaches to project, program, and portfolio management, tailored to the unique challenges of biopharma R&D.
✅ Exclusive Networking – Connect with senior executives, decision-makers, and industry peers in an environment designed for meaningful collaboration and knowledge exchange.
✅ Real-World Case Studies – Discover proven strategies through case studies that showcase successful portfolio management in action and offer recommendations for overcoming common challenges.
✅ Next-Generation Tools & Technologies – Explore emerging analytics, AI-driven insights, and innovative frameworks that drive efficiency and optimize portfolio strategy.
✅ Professional Growth – Enhance your expertise, expand your network, and demonstrate leadership in shaping the future of biopharma decision-making.
“Excellent opportunity to plug into the portfolio and program management community and learn about other approaches to issues we all are faced with.”
- Cynthia Barber, Senior Director Portfolio & Program Management at Vertex Pharmaceuticals
“This was one of the best conferences I have attended focused on Portfolio Management and helping executives take enterprise decisions.”
- Stephen Cho, PhD, Senior Vice President & Head, Portfolio Strategy & Analytics, Strategy & Growth, Novartis